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ABSTRACT
CONTEXT AND OBJECTIVE: Different functional respiratory alterations have been described in acromegaly, 
but their relationship with pulmonary tissue abnormalities is unknown. The objective of this study was to 
observe possible changes in lung structure and explain their relationship with gas exchange abnormalities. 
DESIGN AND SETTING: Cross-sectional analytical study with a control group, conducted at a uni-
versity hospital. 
METHODS: The study included 36 patients with acromegaly and 24 controls who were all assessed 
through high-resolution computed tomography of the thorax (CT). Arterial blood gas, effort oximetry 
and serum growth hormone (GH) and insulin-like growth factor I (IGF-1) were also assessed in the patients 
with acromegaly. 
RESULTS: The abnormalities found in the CT scan were not statistically different between the acromegaly 
and control groups: mild cylindrical bronchiectasis (P = 0.59), linear opacity (P = 0.29), nodular opacity 
(P = 0.28), increased attenuation (frosted glass; P = 0.48) and decreased attenuation (emphysema; P = 0.32). 
Radiographic abnormalities were not associated with serum GH and IGF-1. Hypoxemia was present in sev-
en patients; however, in six of them, the hypoxemia could be explained by underlying clinical conditions 
other than acromegaly: chronic obstructive pulmonary disease in two, obesity in two, bronchial infection 
in one and asthma in one. 
CONCLUSION: No changes in lung structure were detected through thorax tomography in comparison 
with the control subjects. The functional respiratory alterations found were largely explained by alternative 
diagnoses or had subclinical manifestations, without any plausible relationship with lung structural factors.
RESUMO
CONTEXTO E OBJETIVO: Diferentes alterações funcionais respiratórias são descritas na acromegalia. Sua 
relação com anormalidades do tecido pulmonar é desconhecida. O objetivo foi observar possíveis altera-
ções da estrutura pulmonar e explicar sua relação com anormalidades da troca gasosa.
TIPO DE ESTUDO E LOCAL: Estudo transversal, analítico, com grupo de controle, realizado em um hos-
pital universitário. 
MÉTODOS: Incluíram-se 36 pacientes com acromegalia e 24 controles que foram avaliados com tomo-
grafia computadorizada de alta resolução de tórax (TC); os acromegálicos também foram avaliados com 
gasometria arterial, oximetria de esforço e dosagens de hormônio de crescimento (GH) e fator de cresci-
mento semelhante à insulina (IGF-1).
RESULTADOS: As alterações encontradas na TC não foram estatisticamente diferentes entre os grupos 
acromegálico e de controle: bronquiectasia cilíndrica leve (P = 0,59), opacidades lineares (P = 0,29), opaci-
dades nodulares (P = 0,28), aumento da atenuação (vidro fosco) (P = 0,48) e redução da atenuação (enfise-
ma; P = 0,32). As alterações radiológicas não se relacionaram com as dosagens de GH e IGF-1. Hipoxemia 
estava presente em sete pacientes; contudo, em seis deles a hipoxemia poderia ser explicada por condi-
ção clínica subjacente diversa da acromegalia: doença pulmonar obstrutiva crônica em dois, obesidade 
em dois, infecção brônquica em um e asma em um. 
CONCLUSÕES: Não foram observadas alterações da estrutura pulmonar por tomografia de tórax, quando 
comparadas ao grupo de controle; as alterações funcionais respiratórias encontradas são explicáveis em 
grande parte por diagnósticos alternativos, ou se manifestam de forma subclínica, não apresentando rela-
ção plausível com o aspecto da estrutura pulmonar.
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INTRODUCTION
Patients with acromegaly have higher respiratory mortality rates 
when stratified according to gender and age.1 It has been reported 
that patients with acromegaly die prematurely and that mortal-
ity due to respiratory diseases is three times more frequent than 
would be expected in the entire population.1 In that retrospec-
tive study, the type of respiratory disease leading to death was not 
described. A relative mortality risk due to respiratory diseases 
of 1.85, in comparison with that of the general population, has 
been described in the literature. This risk increases to 2.32 when 
the growth hormone (GH) level remains high after treatment, i.e. 
between 2.5 ng/ml and 9.9 ng/ml.2
Many respiratory functional abnormalities have been 
described in patients with acromegaly. Increased lung volume 
was initially described in the 1970s.3-5 There is evidence that GH 
levels are associated with lung volume. Patients with hypopitu-
itarism and GH deficiency have lung volume reductions in com-
parison with acromegaly patients.6 There is some controversy 
regarding the reason for the increase in lung volume. It has been 
suggested that it could be due to the increased number of alveoli.7 
However, it has been observed that the increase in lung compli-
ance found in patients with acromegaly was minimized or even 
disappeared after hormonal control, thus indicating that the rea-
son for the greater lung volume was the increased alveolar size 
and not their number.8
Static lung volumes depend on the elastic properties of the 
respiratory system and muscle strength. Some patients with 
acromegaly show decreases in respiratory muscle strength, 
although the magnitude of this change has not been signif-
icantly correlated with the increased in lung volume, or with 
measurements of partial pressure of arterial carbon dioxide 
(PaCO2) and oxygen (PaO2).9
Increased airflow resistance in patients with acromegaly, with 
reduced flows at low lung volumes, has also been observed, which 
suggests that the small airways are involved,5 as well as clearly 
obstructive lung disease in nonsmoking patients with acromegaly.10
Studying gas exchange is particularly important in this con-
text. On the one hand, it is the result of the sum of variables that 
determines ventilation, diffusion and the ventilation-perfusion 
balance, among others. On the other hand, major gas exchange 
alterations such as severe hypoxemia are directly involved in 
morbidity and mortality rates.11
Varying levels of hypoxemia with increased alveolar-arterial 
oxygen gradients have been described in patients with acromeg-
aly, thereby suggesting the existence of disturbance of the ventila-
tion/perfusion relationship.12 This finding has not been observed 
by other authors.8,9 However, it should be noted that the samples 
of that study were small and there was no investigation of stress-
induced hypoxemia.
To our knowledge, despite the functional alterations 
observed, no patients with acromegaly have been evaluated for 
possible alterations in the lung structure using high-resolution 
computed tomography of the thorax. Only a few observations 
resulting from simple chest X-rays with normal lung parenchyma 
have been reported.4,12
OBJECTIVE
The aim of this study was to investigate whether patients with 
acromegaly show lung structure alterations, in comparison 
with control subjects, and whether these possible alterations are 
related to gas exchange abnormalities.
METHODS
Patients
Patients with acromegaly who were treated at the Neuroendocrine 
Unit of Hospital Universitário de Brasília underwent examinations 
as part of a cross-sectional analytical study with a control group. 
The diagnosis of acromegaly was established based on clinical char-
acteristics and the following biochemical findings:13 lack of growth 
hormone (GH) suppression (less than 1 µg/l) during the stan-
dard oral glucose tolerance test using 75 g of anhydrous glucose; 
and levels of insulin-like growth factor I (IGF-I) that were con-
sidered high for the age and gender. The sample included patients 
with both controlled and uncontrolled acromegaly, as shown by a 
normal IGF-I or glucose tolerance test. Patients presenting uncon-
trolled hypopituitarism were excluded from the study. 
A control group was included to compare the data obtained 
via high-resolution computed tomography (CT) of the thorax, 
with data from other patients who underwent this examination at 
Hospital Universitário de Brasília within the period of this study. 
The exclusion criteria for the control group were clinical evidence 
of respiratory tract disease and acromegaly. This was a convenience 
sample and it was not matched for sex and age. However, the sam-
ples were matched for age and sex by coincidence. Information on 
age, sex and smoking habit was collected from all patients.
GH levels (Immulite 2000, chemiluminescent enzyme 
immunometric methodology, Diagnostic Products Corporation, 
Los Angeles, CA, USA) and IGF-I levels (radioimmunoassay 
after extraction) were used in comparisons involving radiologi-
cal abnormalities and oxygen level.
Functional respiratory examination 
Arterial blood gas analysis was performed by collecting blood 
from the radial artery, with examination via gasometry for less 
than three minutes (AVL Compact 3, USA). The reference value 
for the partial pressure of arterial oxygen (PaO2)14 was corrected 
for the altitude of Brasilia, such that the average atmospheric 
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pressure at the place of examination was 680 mmHg. The lower 
limit was obtained by subtracting the predicted value, which was 
1.96 times the standard error of the estimate.
In conducting the exercise oximetry, a magnetic-type bicy-
cle ergometer (DJ168 Venus, Belo Horizonte, Brazil) was used. 
Increasing effort up to the maximum time of six minutes was 
required. The exercise started without weights and continued 
until it reached a level close to 60 W. The test was immediately 
suspended if a decrease of 4% in peripheral oxygen saturation 
(SpO2) in hemoglobin was observed. A pulse oximeter was used 
(Healthdyne 950, USA) for SpO2 readings.
Radiological examination
The radiological study was carried out using a CT scanner (Light 
Speed QX/I, GE Medical Systems, Milwaukee, WI, USA). High spatial 
resolution sections were made for observations of the lung parenchy-
mal structure. The technique followed sequential acquisition at maxi-
mum inspiratory apnea, with collimation of 2 x 0.625 mm, increments 
of 10 mm and a reconstruction algorithm of high spatial frequency, 
without intravenous administration of exogenous contrast agent.
The findings were consensually described by two radiology 
experts who did not have any previous knowledge of the clinical or 
functional data of each patient, and followed standardized nomen-
clature.14 The findings were grouped into bronchiectasis, lin-
ear opacities, nodular opacities, increased attenuation, decreased 
attenuation, atheromatous aorta, coronary alterations and verte-
bral degenerative abnormalities. Small high-density nodular opac-
ities (calcified granuloma) were excluded from the analysis.
Statistical analysis
Student’s t test was used for statistical analysis of independent sam-
ples and, when pertinent, for comparison of variables between 
the two groups of patients, i.e. with and without acromegaly. 
Evaluation of the normal distribution of each variable was done 
using the Shapiro-Wilk test. When the variable under assess-
ment did not meet the criteria for normal distribution of values, 
the Mann-Whitney test was used. With regard to nominal data, 
the chi-square test was used for proportions. The variables were 
expressed as means ± standard deviations when the data showed 
normal distribution. Otherwise, the variables were expressed as 
medians and interquartile ranges. The findings that were consid-
ered statistically significant were those in which the associated 
probability in two-tailed tests was P < 0.05. The statistical software 
used was the SPSS software for Windows, version 13.0.
Ethics
The study design was approved by the Research Ethics 
Committee of the School of Medicine of the University of Brasília. 
All participants (acromegaly and control groups) gave their writ-
ten informed consent in order to participate in the study.
RESULTS
The sample initially included 19 male and 17 female patients with 
acromegaly. The mean age was 49 ± 12.5 years (range: 24-67 years). 
The mean time elapsed since the diagnosis of acromegaly was 
6.9 ± 5.2 years (range: 7 months to 25.1 years). 
Except for three individuals (8.3%) who were included in the 
study prior to treatment for acromegaly, all the patients had pre-
viously undergone the following therapeutic approaches: surgery, 
radiotherapy and octreotide administration (n = 13; 36.1%); sur-
gery and octreotide administration (n = 8; 22.2%); primary treat-
ment with octreotide (n = 7; 19.4%); surgery only (n = 4; 11.1%); 
and surgery and radiotherapy (n = 1; 2.8%).
The control group included 24 patients, of whom 19 were 
volunteers in another protocol whose objective was to evalu-
ate coronary alterations through CT. The other five patients had 
neoplasia: adenocarcinoma of the pancreas, colon, Hodgkin’s 
lymphoma, gestational trophoblastic disease and basal cell carci-
noma on the face. They underwent CT scans as part of a metas-
tasis screening process.
Table 1 shows potential confounders. There was no statistically 
significant difference between the groups with regard to age, gen-
der or smoking habit. Smoking habit was assessed as a proportion 
of the patients or as the number of pack-years of smoking.
CT of the pulmonary parenchyma showed several abnor-
malities in both groups, as observed in Table 2. In the group 
with increased attenuation, only ground-glass opacity was 
observed, whereas in the group with decreased attenuation, only 
Table 1. Distribution of the acromegaly and control groups 







Age (years) 49.5 ± 12 55.0 ± 17 0.15
Male subjects 53% 58% 0.67
Proportion of smokers 42% 48% 0.64
Pack-years of smoking 0 (0-12) 0 (0-20) 0.68*
*Mann-Whitney test (values expressed as medians and interquartile ranges).
Table 2. Proportion of radiographic abnormalities in the 
acromegaly and control groups obtained by means of high-







Mild cylindrical bronchiectasis 22.2% 16.7% 0.59
Linear opacity 44.4% 58.3% 0.29







Coronary atheromatous disease 11.1% 50.0% < 0.01
Vertebral degenerative 
alterations
83.3% 41.7% < 0.01
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emphysema-type lesions were seen. No nodular opacity had a 
diameter greater than 1 cm. The entire set of lesions observed 
was of small extent. If it had been possible to arrange each set 
of lesions in contiguity for a given patient, the area taken would 
have been less than one bronchopulmonary segment, except for 
emphysema, which was diffuse and extensive. When compared 
with the proportion of parenchymal lesions found in the control 
group, no statistically significant differences were found.
With regard to non-pulmonary alterations seen on thorax 
tomography, a significant difference in the proportion of 
atheromatous alterations was observed. These were greater in the 
control group, and vertebral degenerative alterations were more 
pronounced in patients with acromegaly (Table 2).
Of the 36 patients initially included in the study, 3 refused to 
undergo arterial puncture for blood gas analysis. Of the 33 patients 
who underwent arterial blood gas analysis, 7 (21%) had PaO2 levels 
below the lower limit of normality, but none had levels of respira-
tory failure (PaO2 < 60 mmHg). Among the 7 patients with hypox-
emia, 1 had bronchial asthma with symptoms on the examination 
day, 2 had chronic obstructive pulmonary disease, 2 were obese, 1 
had bronchial infection and 1 had no clinically apparent respira-
tory disease in the assessment of symptoms or lung structure from 
the CT scan. In absolute terms, these patients showed PaO2 levels 
from 0.5 to 4.8 mmHg, i.e. below the lower limit.
Figure 1 shows the distribution of absolute PaO2 values in 
mmHg, and they are relatively low. However, this was not con-
firmed when the values were corrected for the altitude of Brasília 
(PaO2 as % of predicted values). 
Four patients did not undergo exercise oximetry: 1 refused to 
do it, 1 was excluded due to knee arthralgia; 1 was excluded due 
to severe sequelae from pelvic trauma; and 1 was excluded 
due to the presence of coronary disease. None of the 32 patients 
who did undergo exercise oximetry showed decreased SPO2 
during exercise.
As shown in Table 3, the comparisons between PaO2, GH 
and IGF-I values as a function of the presence or absence of 
parenchymal lung abnormalities in each group of tomographic 
alterations were not statistically significant.
DISCUSSION
It has been well established that respiratory alterations in patients 
with acromegaly may be involved in higher morbidity and mor-
tality rates associated with this disease.1,15 Acromegaly patients 
develop various respiratory alterations as a result of anatomical 
changes involving skull and facial bones and soft tissues, carti-
lage, respiratory mucosa, lung volume, rib cage geometry and 
respiratory muscle activity.15
In previous studies on the acromegaly patients who were 
the subject of the present study,16,17 it was observed that hypoxia 
during sleep (defined as more than five episodes of desaturation 
per hour) occurred frequently. It affected 41% of the enrolled 
patients. It was demonstrated that craniofacial abnormalities, 
obesity and GH and IGF-1 alterations have similar effects on 
the magnitude of the development of nocturnal hypoxemia in 
patients with acromegaly.16 Moreover, in evaluating clinical data 
as predictors of this condition, it was found that neck circumfer-
ence greater than 44 cm was the main factor involved, in compar-
ison with other commonly implicated factors such as body mass 
index (BMI), daytime sleepiness and snoring.17 
In this study, the parenchymal lung abnormalities seen on 
high-resolution thorax tomography showed no statistically sig-
nificant difference between the patients with acromegaly and the 
control group. Therefore, no pulmonary findings from this study 
can be associated with acromegaly. It is likely that factors com-
mon to both groups could be responsible, such as smoking. For 
instance, among other abnormalities related to smoking, emphy-
sema is observed in both groups. In addition, it has been shown 
that the severity of sleep apnea syndrome in acromegaly patients 
is related to smoking and lung disease.18
Nevertheless, the association of pulmonary lesions with 
deaths among acromegaly patients is unclear.15 Out of 256 cases 
reviewed, chronic bronchitis and emphysema were found in five 
Figure 1. Distribution of absolute and relatively low PaO2 
values, in mmHg. This was not confirmed when the values 
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patients and bronchiectasis in three other patients.19 In another 
study on 1,362 acromegaly patients, only 11 of them died due to 
smoking, chronic bronchitis, emphysema and chronic obstruc-
tive pulmonary disease.2 These results are consistent with those 
observed in the present study, i.e. no increased frequency of these 
alterations was observed in either the acromegaly or the control 
patients. Corroborating this observation of a lack of relationship 
between acromegaly and lung structural alterations, there were 
also no significant differences in GH and IGF-I levels (Table 3), 
based on the presence or absence of radiological abnormalities in 
any of the lesion groups studied. 
Two additional extrapulmonary observations were noted on 
high-resolution thorax tomography scans. The first was the much 
lower frequency of aortic and coronary atheromatous disease in 
the group with acromegaly, compared with that of the control 
group. In another study, no difference in the frequency of ath-
eromatous plaques was found between acromegaly and control 
patients, although greater thickening of the intima and media 
layers of the carotid arteries was observed among those with 
active or inactive disease.20 It is probable that the results observed 
in the present study reflect significant selection bias in the con-
trol group, since the sample mainly included patients who had 
already been selected for investigation of vascular alterations.
The second observation was the much higher preva-
lence of vertebral degenerative alterations in the acromeg-
aly patients, in comparison with the control group. Indeed, 
arthropathy is an important morbidity factor in these patients, 
affecting the axial skeleton about 52%,21 which is in agreement 
with the data observed.
In this study, the PaO2 levels were below the lower reference 
limit in seven patients (21%), of whom six had clinical conditions 
other than acromegaly to justify such values. Only one patient 
had no apparent reason for hypoxemia. It might be that this was 
a discrepant isolated case with an unusually low value, which is 
not uncommon in interpreting pulmonary function tests,22 and 
this may also have been associated with acromegaly or another 
unapparent condition.
The low hypoxemia magnitude found allows us to question 
its clinical relevance, particularly because of the hypothetical 
association between hypoxemia and respiratory morbidity and 
mortality in patients with acromegaly. In this study, no patient 
showed respiratory failure or decreased SpO2 during exercise and 
there was no relationship between hypoxemia and any radiologi-
cal alterations in the lung structure.
Other authors have studied the behavior of PaO2 in acro-
megaly.8,9,12 One study8 showed only the normal average value for 
the entire group. In another two studies, all of the individual val-
ues were described.9,12 Hypoxemia was present in only one of the 
ten acromegaly patients studied,9 when the same normality cri-
teria used in the present study were applied.23 The other study 
included eleven acromegaly patients who were asymptomatic 
and nonsmokers, and who had normal thorax X-rays.12 Perfusion 
lung scans showed abnormal results in four out of five patients. 
Ten patients for whom PaO2 data were available showed hypox-
emia prevalence of 80%. However, the authors did not define a 
lower normal limit criterion. Four of the patients were obese; one 
presented BMI of 39.3 kg/m2. When the normality criteria used 
in that study23 were applied to these patients, the hypoxia preva-
lence dropped to 70%.12 If PaO2 were to be corrected for BMI,24 
the hypoxemia prevalence would be 50%, which is still a very high 
rate. It is possible that the patients studied by Luboshitzky et  al.12 
showed some pulmonary vascular involvement whose nature has 
not yet been correlated with the presence of acromegaly.
Hypoxemia has intra or extrapulmonary causes. The intra-
pulmonary causes are diffusion and ventilation-perfusion distur-
bances. An association of hypoxemia with pulmonary alterations 
due to acromegaly in a cross-sectional study should be viewed 
with extreme caution, since ventilation-perfusion mismatches 
Table 3. PaO2, growth hormone (GH) and insulin-like growth factor I (IGF-I) values based on the presence or absence of radiological 
pulmonary abnormalities, obtained by means of high-resolution thorax computed tomography
Radiological abnormality PaO2 (%) P
* GH P† IGF-I P†
Bronchiectasis 






no (n = 28) 96 ± 8 2.35 (0.8-4.45) 347 (184-536)
Linear opacity






no (n = 20) 97 ± 9 2.52 (1- 4.7) 317 (214-587)
Nodular opacity






no (n = 29) 97 ± 9 2.2 (1-4.65) 372 (169-556)
Increased attenuation






no (n = 31) 96 ± 9 2.54 (1.1-4.5) 373 (224-557)
Decreased attenuation






no (n = 33) 96 ± 8 2.5 (0.9-4.3) 323 (176-538)
Any alteration






no (n = 11) 98 ± 8 3.1 (1.48-4.8) 408 (299-592)
*Student t test; †Mann-Whitney test.
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are present in a myriad of conditions. Therefore, it is necessary 
to rule out the coexistence of other diseases, particularly non-
pulmonary diseases that cause hypoxia. Obesity, for example, can 
cause hypoxia through a zone of low ventilation-perfusion ratio 
formed in the lower regions due to changes in compliance of the 
thoracic cage.25
When functional respiratory alterations are subtle, a cross-
sectional clinical investigation based on reference values makes 
it harder to distinguish whether alterations are present. Creating 
specific cutoff values to define functional alterations in acromeg-
aly cases would first require definition of which abnormalities are 
clearly associated with this condition.
Longitudinal study designs are particularly interesting in this 
regard, since these make it possible to assess the impact of treat-
ment on disease progression and simplify the issue of control, which 
may be due to the individual himself. However, it is very difficult to 
define a homogeneous cohort with regard to the length of time of 
disease progression because the insidious nature of the disease leads 
to highly variable times between disease onset and diagnosis.
Although there is higher morbidity and mortality relating to 
lung diseases in patients with acromegaly, in comparison with 
healthy individuals,1 it is not clear which respiratory changes can 
contribute to this situation.17,18 The results reported in the pres-
ent paper may contribute towards understanding the pulmonary 
function abnormalities of patients with acromegaly and may pro-
vide data for future research on this topic. 
CONCLUSION
In conclusion, no changes in lung structure were observed on 
thoracic tomography, in comparison with control subjects. 
The abnormalities in respiratory function found were largely 
explained by alternative diagnoses or had subclinical manifesta-
tions, without showing any plausible relationship with the abnor-
mality of the lung structure.
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